DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR AMIODARONE HYDROCHLORIDE

« Back to Dashboard

All Clinical Trials for Amiodarone Hydrochloride

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00000464	Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE)	Completed	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3	1987-04-01	To compare the efficacy of amiodarone to conventional anti-arrhythmic therapy in individuals who had survived one episode of out-of-hospital cardiac arrest.
NCT00000464	Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE)	Completed	University of Washington	Phase 3	1987-04-01	To compare the efficacy of amiodarone to conventional anti-arrhythmic therapy in individuals who had survived one episode of out-of-hospital cardiac arrest.
NCT00000531	Antiarrhythmics Versus Implantable Defibrillators (AVID)	Completed	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3	1992-09-01	To evaluate if use of an implantable cardiac defibrillator (ICD) results in reduction in total mortality, when compared with conventional pharmacological therapy, in patients resuscitated from sudden cardiac death who are otherwise at very high risk of mortality from arrhythmic causes.
NCT00000556	Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)	Completed	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3	1995-03-01	To compare two standard treatment strategies for atrial fibrillation: ventricular rate control and anticoagulation vs. rhythm control and anticoagulation.
NCT00000609	Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)	Completed	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3	1997-05-01	To compare conventional treatment of congestive heart failure (CHF) with two experimental interventions: amiodarone and an implantable cardioverter-defibrillator (ICD).

Clinical Trial Conditions for Amiodarone Hydrochloride

Condition Name

Condition Name for Amiodarone Hydrochloride
Intervention	Trials
Atrial Fibrillation	52
Ventricular Tachycardia	8
Heart Failure	7
Arrhythmia	6

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Amiodarone Hydrochloride
Intervention	Trials
Atrial Fibrillation	66
Tachycardia	16
Tachycardia, Ventricular	15
Heart Diseases	8

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Amiodarone Hydrochloride

Trials by Country

Trials by Country for Amiodarone Hydrochloride
Location	Trials
United States	207
Italy	68
Canada	35
Spain	13
Mexico	13

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Amiodarone Hydrochloride
Location	Trials
Pennsylvania	12
New York	12
California	11
Virginia	10
Texas	10

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Amiodarone Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Amiodarone Hydrochloride
Clinical Trial Phase	Trials
Phase 4	40
Phase 3	30
Phase 2/Phase 3	6

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Amiodarone Hydrochloride
Clinical Trial Phase	Trials
Completed	50
Not yet recruiting	22
Recruiting	21

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Amiodarone Hydrochloride

Sponsor Name

Sponsor Name for Amiodarone Hydrochloride
Sponsor	Trials
National Heart, Lung, and Blood Institute (NHLBI)	6
Sanofi	5
Biosense Webster, Inc.	4

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Amiodarone Hydrochloride
Sponsor	Trials
Other	170
Industry	34
NIH	9

Export unavailable in trial.
Subscribe for complete access.